ATARA BIOTHERAPEUTICS, INC. Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent of $44.30 million as of 2022-12-31, per its 10-K filed 2024-03-28.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Disposal Group, Including Discontinued Operation, Assets, Noncurrent
us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent · last filed 2024-03-28
- 2022-12-31: Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent $44.30M.
- 2022-09-30: Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent $44.30M.
- 2022-06-30: Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent $44.30M.
- 2022-03-31: Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent $44.79M.
| Period end | Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent |
|---|---|
| 2022-12-31 | $44.30M 10-K · filed 2024-03-28 |
| 2022-09-30 | $44.30M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $44.30M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $44.79M 10-Q · filed 2022-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |